Analyst firms · Piper Sandler · SGHT

Piper Sandler SGHT price target and rating history

Sight Sciences Inc. (SGHT) · Health Care

Piper Sandler rates Sight Sciences Inc. (SGHT) Overweight with a $9 price target, as of its latest action on Jan 5, 2026. It has published 3 rating actions on SGHT since August 2021, including 1 upgrade and 1 downgrade. Across 3 firms with a SGHT price target in the last 12 months, the median target is $9. Piper Sandler's target matches it.

Current rating
Overweight
Price target
$9
Median target, all firms
$9
Actions on SGHT
3

Piper Sandler price target on SGHT

$15$10$5.5020222023202420252026
Piper Sandler price target on SGHT, each point a stated target, August 2021 to January 2026. Targets before September 2023 (divided by 3) are adjusted for a stock split, going by the prior target Piper Sandler restated.

Every Piper Sandler rating on SGHT

How other firms rate SGHT

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
H.C. WainwrightBuy$14Oct 15, 2026
UBSBuy$7Jul 28, 2026
Piper SandlerOverweight$9Jan 5, 2026

Questions about Piper Sandler and SGHT

What is Piper Sandler's price target for SGHT?
Piper Sandler's latest stated price target for Sight Sciences Inc. (SGHT) is $9, from its action on Jan 5, 2026.
What is Piper Sandler's rating on SGHT?
Piper Sandler rates SGHT Overweight, a bullish rating, as of Jan 5, 2026.
When did Piper Sandler last change its view on SGHT?
On Jan 5, 2026, Piper Sandler upgrades to Overweight from Neutral, price target $9.
How does Piper Sandler's SGHT target compare with other analysts?
Across 3 firms with a SGHT price target in the last 12 months, the median target is $9. Piper Sandler's target matches it.

More SGHT rating histories

All Piper Sandler ratingsSGHT news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.